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ABSTRACT

In view of the vast number of new nanomaterials (NMs) that require testing and the constraints
associated with animal models, the majority of studies to elucidate nano-toxicological effects have
occurred in vitro; with limited correlation and applicability to in vivo systems and realistic, occupational
exposure scenarios. In this study, we developed and implemented a chronic in vitro model coupled with
lower, regulatory dosages in order to provide a more realistic assessment of NM-dependent
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consequences and illuminate the implications of long term NM exposure. When keratinocytes were
exposed to 50 nm silver nanoparticles (Ag-NPs), we determined that chronically dosed cells operated
under augmented stress and modified functionality in comparison to their acute counterparts.
Specifically, Ag-NP exposure through a chronic mechanism increased p38 activation, actin
disorganization, heightened ki67 expression, and extensive gene modification. Additionally, chronic
Ag-NP exposure altered the way in which cells perceived and responded to epidermal growth factor
stimulation, indicating a transformation of cell functionality. Most importantly, this study demonstrated
that chronic exposure in the pg/mL range Ag-NPs did not induce a cytotoxic response, but instead
activated sustained stress and signaling responses; suggesting that cells are able to cope with prolonged,
low levels of Ag-NP exposure. In summary, we demonstrated that through implementation of a chronic
dosimetry paradigm, which more closely resembles realistic NM exposure scenarios, it is possible to
illuminate long-term cellular consequences which greatly differ from previously obtained acute
assessments.

KEYWORDS: Chronic Exposure; Occupational dosage; Silver Nanoparticle; Stress Response; Gene
Regulation; Risk Assessment

In light of their novel physicochemical properties nanomaterials (NMs) possess unlimited potential to
advance current technologies in a diverse number of specialties. However, one considerable drawback
is the unintentional cellular consequences that result following NM exposure, thus giving rise to the
field of nanotoxicology.1,2 Members of the scientific community have begun addressing the safety of
NMs, evaluating their potential impact in terms of acute toxicity;3,4 however their true influence in a
physiological system has yet to be fully elucidated. This lack of current knowledge is due to a number
of limitations, including poor NM characterization, incomplete study design, an inadequacy in the
translation of in vitro results to an accurate in vivo prediction, and the inability to assess NM-induced
bioeffects in a manner accurately representing a realistic exposure scenario.5-7 Currently, the lion’s share
2

of studies being performed employ an in vitro model due to time- and cost-restraints associated with
animal models, as well as the sheer number of NMs that require testing.8 These studies have identified a
number of NM-induced bioeffects including augmented cellular stress, DNA damage, secretion of proinflammatory and immune markers, and cytotoxicity; indicating a high potential for long term health
concerns associated with NM exposure.9,10 However, there exists serious conflict with correlating acute,
24 hour in vitro NM exposure findings to a chronic in vivo model, illuminating the critical need for a
new approach to feasibly and reliably assess NM consequences in cell culture.11,12 One possible
mechanism to increase NM-predictive modeling with in vitro systems is to extend exposure from acute
to chronic durations.

While minimal data exists regarding chronic NM introduction, one study

successfully identified that after 24 weeks of exposure to carbon nanotubes, lung cells underwent a
malignant transformation and developed a resistance to apoptosis.13 This example clearly demonstrates
why it is critical to examine long term NM bioeffects, as they were able to capture endpoints
unobtainable through acute evaluation.
With regulatory guidelines already established on acceptable metallic exposure levels for bulk
materials from agencies such as the Occupational Safety and Health Administration (OSHA) and the
National Institute for Occupational Safety and Health (NIOSH), occupational limits have been set well
below the high, dose-dependent concentrations typically examined in traditional nanotoxicology
studies.14 However, as nano-sized particles exhibit highly energetic and reactive properties significantly
different from their bulk counterparts, the permissible exposure levels (PELs) of these metallic NMs
will in all likelihood be even lower than the current bulk guidelines, once they are instituted. In fact,
NIOSH has established guidance15 on micron and nanosized titanium dioxide (TiO2) materials that is
considerably lower than the regulations for bulk TiO2. Previously, the PEL for bulk TiO2 exposure was
listed at 15 mg/m3 with a 5 mg/m3 limit on the respirable fraction which accounted for the “fine” or
micron sized exposures. After multiple in vitro, in vivo, and modeling studies were published the
respirable limit has been lowered to distinguish between micron sized and nanosized TiO2, with a PEL
of 2.4 mg/m3 and 0.3 mg/m3 for micron- and nano-sized TiO2, respectively. However, one of the
3

challenges associated with establishment of regulatory NM exposure guidelines is that the incomplete
and conflicting reports of nanotoxicological responses make it impossible to set an exposure limit with
confidence,16 therefore, other frequently used NMs still do not have any revised regulations. Taken
together, these issues further demonstrate the need for an enhanced means of examining NM bioeffects;
including occupational exposure guidelines as a benchmark and developing a dosimetry paradigm that
more accurately reflects real world exposure scenarios.
To address these aforementioned necessities, we designed and implemented a chronic, in vitro
exposure model for the improved safety assessment of NMs at low, realistic dosages. Keratinocytes, the
HaCaT cell line, underwent daily exposure for 14 weeks to 50 nm silver nanoparticles (Ag-NPs) at
levels based on the permissible OSHA limits for bulk silver. Ag-NPs were chosen as a proof of concept
for this study as their bioresponses have been extensively studied and are well established, providing a
baseline for experimental design.17-21 The stress response of these chronically dosed cells was evaluated
and directly compared against a 24 hour acute exposure at a concentration equal to the cumulative AgNP dosage the chronically exposed cells encountered over the 14 week study (Figure 1). Our analysis
revealed that chronically dosed HaCaTs functioned under augmented cellular stress and altered
functionality, as evaluated through several key endpoints focused on stress markers, gene regulation,
and cellular response to epidermal growth factor (EGF) stimulation.

We believe that this study

demonstrated the capability of a chronic dosimetry paradigm to provide enhanced in vitro assessments
and to elucidate sustained cellular responses to NM exposure.

RESULTS AND DISCUSSION:
Chronic exposure model: System design requirements and procedures. The critical design
elements incorporated into this chronic in vitro model included; 1) a mechanism for daily delivery of a
precise, low NM dosage, 2) the ability for an extended experimental time frame, and 3) the
incorporation of a characterized, robust non-cancerous cell line. As dermal contact is a primary source
of NM exposure22 the keratinocyte cell line, HaCaT, was selected for this proof of concept study, owing
4

to its establishment as a model for nanotoxicology investigation and its well-documented cellular
processes.23,24 Furthermore, HaCaTs have been repeatedly used for investigations into intracellular fate
and behavior of NMs;25,26 resulting in a sound understanding of how these cells respond following NM
challenge. Additionally, the use of HaCaTs is further validated by the fact that this immortalized cell
line was isolated from the basal layer of the epidermis, which has been shown to be a principle location
of particle accumulation, independent of mode of NM entry.27
For chronic exposure, the HaCaTs were sub-cultured weekly in 6-wells plates and dosed with
predetermined concentrations of NMs for 8 hours a day, 5 days a week, for a duration of 14 weeks
(Figure 1). This model was designed to mimic an occupational exposure scenario as closely as possible
under the constraints of an in vitro setting. After the 8 hour exposure, the NM-contained media was
removed and stored for later examination, while the cells were washed and replenished with fresh
media. The HaCaTs were split weekly to an optimized density of viable cells, followed by their initial
growth for 64 hours free of NMs; representative of a worker’s removal from NM contact over the
weekend.

Negative controls, which incurred no NM introduction, were included in the chronic

experimental design to identify any cellular modifications due to an aging effect.
8 hr/day, 5 days/week
at chronic doses

Chronic

3 months

Fresh
Cells

Acute

Chronic
doses
24 hr

Acute
doses

Cellular
Endpoints

24 hr
Fresh
Cells

Figure 1. Timeline for chronic and acute Ag-NP exposure. At the onset of experimentation, identical
vials of fresh HaCaTs were prepared and stored. Chronically exposed cells underwent NM exposure 8
hours per day, 5 days a week for 14 weeks. After that duration, fresh cells were prepared for acute trials
and all HaCaTs underwent a 24 hour NM exposure to allow for direct and simultaneous comparison of
acute and chronic dosimetry conditions. Cellular endpoints that targeted the stress and EGF signaling
response were then evaluated.
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Silver nanoparticle selection and dosimetry. For the initial test of the designed chronic exposure
system, silver nanoparticles (Ag-NPs) were viewed as advantageous for multiple reasons, and thus
selected as the choice NM.

Firstly, cellular behavior following Ag-NP introduction has been

extensively studied with robust cytotoxic and stress responses well-documented.18-20 Furthermore, due
to their antimicrobial and plasmonic properties, Ag-NPs incur the highest incorporation in consumer and
medical products to date.28 As the majority of these products have direct contact with the skin,
including clothing, cosmetics, bandages, and personal electronics, the selection of silver as a proof of
concept for the chronic HaCaT model was especially appropriate. Additionally, OSHA and NIOSH
regulatory guidelines exist for silver, in bulk form, providing an initial dosage set-point for testing AgNP concentrations at more realistic, occupational exposure values (Table 1). Established safety limits
for bulk silver are provided for soluble form, insoluble form, and levels that are “immediately dangerous
to life and health” (IDLH).

Table 1. Chronic Dosages were Calculated from Established Occupational Exposure Levels
OSHA Safety Limits for Silver
Soluble Level
Insoluble Level
IDLH

10 pg/mL
100 pg/mL
10 ng/mL

Chronic Dosage
(4% of OSHA Limit)
0.4 pg/mL
4 pg/mL
400 pg/mL

Acute Dosage
(Chronic dose x 70 days)
28 pg/mL
280 pg/mL
28 ng/mL

Owing to the vast differences in physical properties when a bulk material is reduced down to the
nanoscale and lack of regulatory guidelines for NM exposure, selection of meaningful dosages for
nanotoxicity examinations has always been a major challenge.

For this study, daily exposure

concentrations of Ag-NPs were based off the OSHA regulatory values for bulk silver and incorporated
an adjustment to account for the fact that 2-4% of all introduced Ag-NPs, independent of mode of
exposure, are retained in the skin (Table 1).29 As no regulatory values for Ag-NPs are currently in place,
these chronic dosages, spanning 0.4 to 400 pg/mL, which combined bulk occupational limits and known
retention rates, provide a plausible NM daily exposure range. The acute exposure Ag-NP concentrations
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were equivalent to the cumulative mass of Ag-NPs encountered over the 14 week duration (70 days of
exposure), thus removing the variable of total mass from this experiment. As seen from Table 1, both
the chronic and acute dosages are well below the traditional dose-dependent concentrations previously
examined, which are typically in the µg/mL range.
Nanoparticle characterization. To verify particle quality and assess target parameters, extensive
characterization of the 50 nm Ag-NPs was performed prior to cellular introduction (Table 2).30,31 TEM
imaging confirmed the primary particle size of approximately 50 nm and spherical morphology (Figure
2A). The degree of Ag-NP agglomeration and zeta potential were ascertained in growth media, as that
is the primary working environment in this study. A slight increase in effective particle diameter was
determined, and is in agreement with the minimal aggregation brought on by the creation of a protein
corona.32 Furthermore, there was little variation in agglomerate size indicating a uniformly
monodispersed set of Ag-NPs. The zeta potential analysis identified a particle surface charge of -10
mV, which is brought about by the formation of a protein corona with negatively charged serum
proteins.33 To verify the known cytotoxic response of this Ag-NP stock, a traditional dose dependent
viability assessment was performed to determine the LD50 value, which was found to be 54.3 µg/mL
(Table 2, Supporting Information Figure 1A).

Table 2. Silver Nanoparticle Characterization
Assessment
Primary size (nm)
Agglomerate size (nm)
Zeta potential (mV)
Ionic dissolution (%)
Deposition efficiency (%)
LD50 (µg/mL)

Start of Study - Media
54.3 ± 5.3
101.9 + 3.3
-9.90 + 0.4
0.32 + 0.04
52.8 + 4.8
54.3

End of Study - Media
52.5 ± 5.1
142.1 + 10.8
-9.2 + 0.2
0.62 + 0.01
59.9 + 7.0
47.7

Lysosomal Fluid
-336.8 + 17.5
-5.9 + 0.4
8.89 + 0.07
---

It has been identified that the physicochemical properties of NMs can alter over time, thus modifying
the nature of both the nano-cellular interface and the induced bio-responses.34 Therefore, Ag-NP
characterization was also performed at the end of the three month study to ascertain if any time7

dependent modifications existed (Figure 2B and Table 2). From the TEM image, a small degree of
particle fusing was identified with the older Ag-NP samples. This modification was also reflected in the
DLS data in which a minimal increase in particle agglomeration existed after the 14 week duration;
although still not to a large extent. A slight drop in the LD50 value was found, which is in agreement
with published reports that indicated a time dependent increase in the toxic potential of Ag-NPs.35 On
the whole, however, minimal modifications to the Ag-NPs were seen throughout the duration of this
study, indicating the particle quality and behavior were retained.

Figure 2. Time Dependent Characterization and Internalization of Ag-NPs. Representative TEM
images of 50 nm Ag-NPs (A) at the beginning of chronic exposure and (B) at the end of the 14 week
study. (C) After 14 weeks of exposure to low dosages of Ag-NPs the degree of Ag-NP internalization
was ascertained.

Fluorescent images captured the internalized Ag-NPs at the end of the chronic

dosimetry following daily exposure to (D) 0.4 pg/mL, (E) 4 pg/mL, and (F) 400 pg/mL. HaCaT cells
underwent actin (red) and nuclear (blue) staining with metallic NPs reflecting white.

As the dissociation of Ag-NPs into elemental ions has been identified as a root cause of
nanotoxicity,36 the percent dissociation of the Ag-NPS after 8 hours in media was evaluated to
determine if this phenomenon would be a major factor. At the start of the study, the generation of silver
ions was found to be minimal, only a 0.32% dissolution rate (Table 2). As NP age has been shown to
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dictate the kinetic rate of dissolution,

35

this analysis was repeated after 14 weeks. At the end of the

study, the 50 nm Ag-NPs did display a higher degree of silver ion generation, however, this final rate
was still a minor factor, only 0.58%.
The deposition efficiency at the 400 pg/mL chronic dosage was evaluated to determine the extent of
Ag-NP/HaCaT association. After 8 hours incubation, it was quantitatively determined that
approximately 55% of the Ag-NPs were either internalized or strongly associated with the cellular
environment (Table 2). It was also found that Ag-NP age had a negligible influence on this aspect of
particle behavior. Following binding to the cell surface, NPs are typically internalized through a
combination of endocytosis mechanisms, temporarily stored in intracellular vesicles, and marked for
either degradation or exocytosis.37,38 Owing to the facts that NPs are internalized into lysosomes and
that NMs display significantly altered behavior in physiologically relevant environments, 34,39 the AgNPs were re-characterized in artificial lysosomal fluid (ALF). Following an 8 hour incubation in ALF
at 37 ᵒC, evaluation of the agglomerate size, zeta potential, and ionic dissolution of the Ag-NPs were
carried out with a substantial increase identified for NP agglomeration and dissolution rate (Table 2).
Due to previous reports and the low pH of ALF,40 these results were not surprising, however, they are
significant as they demonstrate the potential for increased ion production following internalization.
Another dosimetry concern is that due to the continual proliferation of cells and the fact that the rate
of NP internalization is a function of cell cycle state,41 cells within a culture are not necessarily exposed
to equal NP quantities. However, the daily exposure incorporated into the design of this study should
minimize this variability, as HaCaT cells were continually exposed to Ag-NPs throughout their cell
cycle progression; normalizing the quantity each cell was exposed to over its life cycle.
In light of the importance of dosimetry and uptake, the ability of HaCaTs to internalize Ag-NPs over
an extended time frame was assessed quantitatively and qualitatively through ICP-MS and CytoViva
imaging, respectively (Figures 2C-2F). We identified small amounts of intracellular Ag-NPs from both
analyses after 14 weeks of daily exposure, further validating the observed degree of Ag-NP deposition
and slow dissolution rate at the tested low dosages.
9

Long Term Ag-NP Exposure Resulted in Augmented and Sustained Stress Responses. Firstly,
after 14 weeks exposure, the HaCaTs exhibited a minimal change in the number of viable cells
(Supporting Figure 1B); with a slight diminishment in cell number (less than 10%) associated with the
400 pg/mL condition. This response is believed to be due to a decreased cell growth rate as a result of
elevated stress levels, and not necessarily the induction of apoptosis.42 It is also imperative to highlight
the fact that at levels in the pg/mL region, the HaCaTs were able to handle sustained Ag-NP exposure
without the subsequent cytotoxic response, typically associated with nanosilver. Next, a primary set of
endpoints were developed around the evaluation of recognized stress markers, and included target
protein activation, actin coverage, cytokine secretion, and modifications to gene regulation. To interpret
the role of daily 50 nm Ag-NP exposure, chronically exposed HaCaTs were directly compared to cells
that underwent a 24 hour, acute exposure to a dose equivalent to the cumulative Ag-NPs encountered by
the chronic cells (Figure 1 and Table 1).

Results from these analyses demonstrated a distinct,

differential response between chronically dosed HaCaTs at the 400 pg/mL concentration and their acute
counterpart (28 ng/mL); with chronic exposure resulting in an amplified, sustained stress reaction
(Figure 3). Furthermore, the cellular responses to Ag-NP concentration at the 0.4 and 4 pg/mL dosages
produced very similar result patterns to the 400 pg/mL data sets; which we believe to be due to the fact
that at these extremely low dosages, cells are not able to accurately sense the difference in Ag-NP
concentration. Therefore, for conciseness, the 0.4 and 4 pg/mL results are presented in Supporting
Information Figures 2 and 3.
The p38 mitogen-activated protein kinase family members have been shown to be activated by a
variety of extracellular stress stimuli and initiate a hierarchy of protein and transcription regulators of
apoptosis, immune response, migration, and gene regulation.43 Chronic stimulation with low levels of
Ag-NPs resulted in an increase of the phosphorylation and activation of p38 over control and acutely
dosed samples (Figure. 3A). While acute exposure to Ag-NPs has been previously shown to increase
p38 activation in other biological models,44,45 at the low dosages selected for this study no such increase
10

was detected. One downstream response of stress-induced p38 is the reorganization and increased
expression of actin filaments.46 With increased degrees of cellular stress the actin loses its normal
structure and becomes disorganized; as shown following chronic exposure (Figure 3B). While both
acutely and chronically exposed cells indicated a larger percentage of actin coverage over controls, the
chronic cells displayed a higher degree of disruption; as easily identified by the globular nature of the
actin in the representative confocal images.

A

A-400

*‡

B

A-400

*‡
*
C-400

C-400

C

A-400

*‡

D
‡

‡

C-400

Figure 3. Ag-NP Induced Stress Response is Dependent on the Means of Exposure. Evaluation of
known cellular stress responses was carried out following introduction of 50 nm Ag-NPs through either
an acute (A-400) or chronic (C-400) exposure scenario. (A) Confocal imaging evaluation of p38 signal
transduction activation was performed through detection of the phosphorylation state (green) and
normalized by total p38 (red). Included are representative confocal images of acute and chronically
dosed cells. (B) Degree of actin (red) coverage over the cellular area was determined and representative
images included under acute and chronic conditions for Ag-NP introduction. (C) The number of cells
that were actively expressing ki67 (pink) and its cellular localization were evaluated in acutely and
chronically dosed HaCaT cells. (D) The quantities of secreted pro-inflammatory cytokines IL-6 and
TNF-α were ascertained through ELISA experimentation. Recall, equivalent acute dosage for the 400
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pg/mL condition was 28 ng/mL. For all figure sections, a two way ANOVA with Bonferroni post-test
was run with * denoting significance from untreated and ‡ denoting significance from the acute at the
same concentration. (n=3, p<0.05)

In addition to its recognized role in cell proliferation, ki67 also has a critical secondary function in the
repair of damaged DNA.47 As Ag-NP cellular exposure has been strongly correlated to DNA damage,48
the activation and location of ki67 was of great interest to this study. Our results demonstrated an
enhanced ki67 expression in chronically dosed cells as well as both nuclear and cytosolic localization,
with no significant alterations noted in the acute cells (Figure 3C). We hypothesize that this augmented
expression is due to the continual synthesis of ki67 over the course of this experiment, in an attempt to
repair the persistent DNA damaged caused by Ag-NP presence. The cytosolic identification is indicative
of excess ki67 cellular production and its directed shuttling out of the nucleus for targeted degradation,
supporting the supposition of its role in DNA damage.
Beyond stress markers Ag-NPs have been linked to the induction of the inflammatory response, which
if found to be sustained could introduce serious health implications.49 One early stage action of the
inflammatory response is the cellular secretion of pro-inflammatory cytokines, including IL-6 and TNFα. For both the Ag-NP treated and un-treated chronic conditions, a significant amount of IL-6 was
produced from the HaCaT cultures (Figure 3D), indicating that this phenomenon could be an aging
effect of the chronic growth conditions, and not specific to Ag-NP stimulation. To verify this, a time
course analysis was performed (Supporting Information Figure 3B) that demonstrated sustained
secretion kinetics, brought on by the daily removal and washing processes which continually disrupted
the cellular accumulation and equilibrium of IL-6. The concentration of secreted TNF-α was also
evaluated with negligible quantities detected for all experimental conditions (Figure 3D).

Taken

together, these data sets indicate that the low chronic Ag-NP concentrations did not substantially active
pro-inflammatory responses.
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As chronically dosed HaCaTs displayed augmented cellular stress responses compared against acute
exposure, we hypothesized that genetic modifications were also present in stress dependent genes. The
legitimacy of this supposition was evaluated using a stress and toxicity focused, real time PCR array.
This PCR array profiled the expression of 84 genes that have been previously identified as key
regulators of cellular stress and apoptosis responses. The array analysis identified that both acutely
dosed and chronically undosed cells displayed modified gene regulation for 3 of the 84 examined genes
(Table 3). Following acute Ag-NP exposure, as expected, there was an increase in heat shock protein
(HSP) and DNA repair genes. HaCaT aging controls showed an upregulation of IL-6, in agreement
with previous data. However, while these conditions demonstrated only slight modifications to stress
and toxicity based gene regulation, HaCaT cells chronically dosed with regulatory-based Ag-NP
concentrations displayed a considerable alteration to their genetic profile with 12 of the 84 genes
undergoing a significant variation (Table 3).
Table 3. Enhanced Stress-Based Gene Modulation Following Chronic Exposure
Fold Change over control cellsa
Stress Response Genes

Acute – 28

Chronic – 0

Chronic –

ng/mL

pg/mL

400 pg/mL

Gene

Function

CCL21

Immunoregulation & inflammatory response

-

-

-3.37

CCND1

Cell cycle progression

-

-

2.94

CYP1A1

Metabolism and lipid synthesis

-

2.56

3.31

CYP7A1

Metabolism and lipid synthesis

-

-

-3.15

EGR1

Differentiation and mitogenesis

-

-

2.45

GDF15

Differentiation and maintenance

-

-

2.23

GSTM3

Stress response

-

-

2.40

HSPA1L

Stress response

3.62

-

-

HSPA8

Stress response

2.05

-

2.50

IL6

Inflammatory response

-

5.72

6.09

PTGS1

Inflammatory response

-

-2.61

-3.69

RAD23A

DNA damage

3.71

-

3.60

SERPINE1

Fibrinolysis inhibitor

-

-

6.12

a

Reported genes displayed a ≥ 2.0 fold regulation over the control (acute undosed condition) and
statistical significance. Data represents three independent trials with p < 0.05. “-“ indicates that no
statistically significant change was observed.
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From this analysis it was identified that the primary genes altered following chronic Ag-NP exposure
fall into the classes of inflammatory response, stress response, and cell regulation. While the stress and
inflammatory activators were expected from previous results, the marked alteration to genes involved in
cellular regulation indicated that sustained disruption to cellular homeostasis occurred; as fundamental
cellular behavior is dictated by gene regulation. Furthermore, the identified genes regulated in the
chronic undosed controls were all equally modified in the chronically dosed conditions, validating the
supposition that they are aging related effects.

Taken together, this study identified that chronic

exposure to Ag-NPs induced a considerable alteration to the basal gene regulation involved in the stress
response, with previously unexplored biological consequences.

Altered EGF Signal Transduction Efficiency. From these results, it is clear that HaCaT cells
undergoing chronic exposure to 50 nm Ag-NPs developed high basal stress levels and displayed
substantial genetic modification. Therefore it appeared highly probable that the functionality of these
cells also became modified over the duration of this study. The primary function of keratinocytes is to
recognize and respond to EGF stimulation, resulting in a proliferative, migratory, or anti-apoptotic cell
outcome. Based on the known importance of EGF signal transduction in keratinocyte behavior, the fact
that EGF signaling has been previously altered by the presence of Ag-NPs,20 and that excessive cellular
stress has been linked to a modification of EGF receptor (EGFR) expression,50 EGF signaling efficiency
was selected as the best metric to evaluate HaCaT functionality. Following EGFR activation, one of the
first dependent signaling events is the induction of the PI3K/Akt and the Ras/Erk pathways. Evaluation
of the phosphorylation states of both Akt and Erk revealed a higher degree of activation of these key
signaling proteins in the chronically dosed experimental conditions (Figure 4 and Supporting
Information Figure 4).

Interestingly, at these reduced Ag-NP levels, the acutely dosed samples

demonstrated no alterations compared to control cells, indicating that this response was progressively
built up over time.
14

Going further into the EGF-dependent signaling response, a PCR array analysis, focused on EGF
signal transduction genes, was performed to identify any alterations to the EGF signaling network on the
genetic level (Table 4). The genes profiled in this real time PCR array have all been strongly linked to
signaling dependent activation following EGF stimulation. Analogous to the previous stress-based gene
array results, acutely dosed and chronic undosed displayed minimal alterations, with only 1 gene
modified of the 84 examined.

On the contrary, chronic introduction of Ag-NPs induced high

modifications to the HaCaT genetic response following EGF stimulation. The classes of genes targeted
by chronic exposure are primarily signaling and matrix/migration genes. Of particular interest is the
overexpression of Akt, MAPK, PRKCA, STAT3, and STAT5A, which are major signal transduction
mediators and are in agreement with the observed increased EGF-dependent signaling. Additionally,
chronically dosed cells displayed an over 9 fold up-regulation of MMP7, which is downstream of p38
and responsible for breaking down extracellular matrix.51 When taking the previously identified increase
in expression and disorganization of actin filaments under consideration, it suggests that the
overexpression of MMP7 could be a cellular defense mechanism to counteract this response.

15

A
*‡

B

‡

Figure 4. Modification to EGF-Dependent Akt and Erk Activation. The ability of Ag-NPs to influence
the efficiency of EGF-dependent signal transduction was evaluated through the extent of (A) Akt
phosphorylation and (B) Erk phosphorylation following stimulation with 10 ng/mL EGF. Recall,
equivalent acute dosage for the 400 pg/mL condition was 28 ng/mL. A two way ANOVA with
Bonferroni post-test was run with * denoting significance from untreated and ‡ denoting significance
from the acute at the same concentration. (n=3, p<0.05)

The EGF receptor contains two primary tyrosine sites for phosphorylation (Y1068 and Y1173). The
tyrosine site that is selectively phosphorylated dictates the mechanism through which the cells respond
to EGF. Moreover, the balance between Y1068 and Y1173 selection has been previously shown to be
susceptible to oxidative stress.52 As the HaCaT response to EGF stimuli was seen to be significantly
different for acutely versus chronically dosed cells, it logically follows that this tyrosine selection was
also modified. For chronically dosed cells, Y1068 was preferentially phosphorylated, while the acutely
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dosed cells enhanced Y1173 phosphorylation (Supporting Information Figure 4). This transformed
means of EGF receptor activation coupled with the genetic modifications, we believe, resulted in the
ability of the chronically dosed cells to display a modified innate response to EGF stimulation, as
proven through enhanced signaling efficiencies.

Table 4. Alteration to EGF-Dependent Gene Regulation by Chronic Ag-NP Exposure
Fold Change over control cellsa
EGF Dependent Genes

Acute – 28

Chronic – 0

Chronic –

ng/mL

pg/mL

400 pg/mL

Gene

Function

AKT1

Cell cycle progression, signaling, and survival

-2.57

-

-

AKT3

Cell cycle progression, signaling, and survival

-

-

4.27

BCAR1

Cell migration

-

-

2.22

CCND1

Cell cycle progression

-

-

2.90

FN1

Cell adhesion and migration

-

9.86

5.06

MAP2K7

MAPK protein involved in stress signaling

-

-

2.04

MMP7

Breakdown of extracellular matrix

-

-

9.40

PRKCA

Signaling protein with multiple roles

-

-

3.94

STAT3

Mediates cellular response to growth factors

-

-

2.08

STAT5A

Mediates cellular response to growth factors

-

-

2.13

a

Reported genes displayed a ≥ 2.0 fold regulation over the control (acute undosed condition) and
statistical significance. Data represents three independent trials with p < 0.05. “-“ indicates that no
statistically significant change was observed.

Chronic Ag-Np Exposure Generates an Augmented Stress Response. The fact that Ag-NPs
introduced a cellular stress response is not a new concept to toxicologists;18,20,21 however the sustained
bioeffects observed as a result of sustained exposure is a growing concern that needs to be further
explored. The results presented here indicated that even at exceptionally low concentrations of Ag-NPs,
chronically dosed HaCaT cells displayed an augmented, sustained cellular stress response.

The

numerous endpoints and multiple Ag-NP concentrations tested further support this conclusion.
Furthermore, Ag-NPs are notoriously recognized for their ability to induce a strong cytototoxic
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response,17,19 however, in this study chronic introduction of regulatory dosages were associated with
negligible loss of cell viability.
The Ag-NP dependent induction of stress markers has previously been shown to be dose dependent,19
which makes these results even more intriguing. As chronically dosed cells displayed a higher stress
response versus the acutely dosed, this indicates that the degree of stress activation is not only a function
of particle concentration, but also of exposure duration. This supposition was further verified by
examination of the HaCaT stress and signaling responses following a 5 μg/mL acute exposure
(Supporting Information Figure 5). For all experimental endpoints, the extremely higher 5 μg/mL dose
correlated with a lower induction of stress than was seen with the 400 pg/mL chronic condition. This
analysis suggests that no matter what dosage is used, chronic NM exposure results in biological
responses unobtainable from acute methodologies. As such, it appears probable that the HaCaT cells not
only built up these cellular responses over time, but that their genetic makeup was altered in such a way
that allowed for adaptation to continual stress. In agreement with the stress results, acute exposure to 5
μg/mL Ag-NPs produced a differential EGF signaling response with an approximate 20% drop in Akt
and Erk phosphorylation. This comparison between acute and chronic EGF signaling supports the
aforementioned supposition of modified functionality, as how keratinocytes respond to EGF is a critical
part of their innate behavior.

Extended Retention and Ionic Dissolution of Ag-NPs. As earlier discussed, Ag-NPs are being
rapidly included in a score of consumer products, including medicines, clothing, toothpaste, cosmetics,
food storage containers, home appliances, and bandages.28

When taken together it appears that

consumers are experiencing nearly continuous exposure to engineered NMs; necessitating the
performance of long-term exposure studies. Moreover, it has become apparent that the cytotoxic and
antimicrobial potential of Ag-NPs is due to the ionic dissolution and the generation of silver ions.34,36 In
fact, a recent study found that silver was released from antibacterial fabrics in an artificial sweat
solution,53 demonstrating the potential of silver particles and ions to be transported from that material to
18

skin in low dosages over an extended duration. This fact, coupled with our findings that cells are able to
retain Ag-NPs following exposure at extremely low dosages, introduces the question of whether the
observed chronic effects were brought on by the Ag-NPs themselves, the generated silver ions, or a
combination of both.
To answer this question, HaCaTs were chronically exposed to silver nitrate at the equivalent Ag-NP
concentration (400 pg/mL) or a concentration equal to the determined dissolution rate after 8 hours in
media (1.28 pg/mL). After a duration of 14 weeks, these silver-ion exposed cells underwent the same
stress and EGF signaling endpoint analyses as performed on the Ag-NP exposed HaCaTs (Figure 5). It
was found that exposure to 1.28 pg/mL silver nitrate had a negligible impact on HaCaT cultures (Figure
5A). While the 400 pg/mL silver nitrate did cause stress responses, it was not comparable to the
quantities associated with chronic Ag-NP introduction. Furthermore, Akt and Erk phosphorylation states
remained unchanged following chronic exposure to low levels of silver nitrate (Figure 5B), in direct
contradiction to Ag-NP treated cultures. Lastly, these dosages of silver nitrate did not impact cell
viability over the course of this experiment (Supporting Information Figure 6). Taken together, these
results suggest that the observed, sustained bioresponses to Ag-NPs are a combination of both the
disruptive presence of the particles themselves and the production of silver ions through dissolution.
We believe that this joint NP and ion explanation is founded in the fact that Ag-NPs are retained within
cells over time, which compounds the production of ions and initiation of stress, owing to the fact that
increased dissolution was associated with a lysosomal environment. While this does not completely
elucidate the mechanisms behind the observed stress and signaling responses to chronic Ag-NP
exposure, it does provide valuable insight in how the continued exposure and particle retention may be
induces cellular modifications.
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Figure 5. Bioeffects of chronic exposure to silver ions. Following sustained exposure to silver nitrate
at dosages of 1.28 pg/mL (C-1.28) and 400 pg/mL (C-400) the stress and signaling responses were
evaluated and compared against the chronic 400 pg/mL Ag-NP data (C-Ag-NPs). (A) Expression
levels of p38, actin, and ki67 were determined through immunofluorescence and compared against an
acute untreated control. (B) Normalized phosphorylation levels were assessed following exposure a 2
hour exposure to 10 ng/mL EGF. For all data sets, a two way ANOVA with Bonferroni post-test was
run with * denoting significance from the untreated acute control and ‡ denoting significance between
400 pg/mL silver nitrate and Ag-NP conditions. (n=3, p<0.05)

Can this New NM Exposure Paradigm Aid in Establishment of Regulatory Limits? This study
presents a new means through which the cellular responses of NMs are evaluated; implementing a
chronic in vitro model in conjunction with low NM dosages. This system was designed to mimic an
occupational exposure, in which NMs are introduced 8 hours a day and 5 days per week at levels based
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on OSHA guidelines.

Herein lies a major concern; that there is limited to no regulatory and

occupational exposure limits in place for NMs, due to the conflicting reports of their dependent cellular
responses14 and lack of correlation between in vitro and in vivo systems.12
One long term goal of this work is to evaluate whether this chronic in vitro model can be extrapolated
to improve in vivo response predictions. As extended NM exposure allows for the cells to modify their
behavior and establish a new basal homeostasis, we believe it offers a plausible mechanism to bridge the
gap between in vitro and in vivo models, improve correlation efficiencies, and aid in the establishment
of NM regulatory guidelines. Included within these future plans are to expand cell models beyond
HaCaTs to include additional, key organs targeted by NMs, such as neuronal, liver, and kidney cell
lines.54,55 Through the combination of coupling specific NMs to their known cellular targets and the
application of the chronic exposure model, we believe this will provide a conceivable means for a finely
honed analysis of predictive toxicological responses that accurately aligns with previous in vivo data.

CONCLUSIONS:
In this study, an in vitro model was successfully designed and implemented to provide a mechanism
to assess implications of NMs at realistic exposure levels over an extended period of time. This distinct
approach allowed for the utilization of low, regulatory doses applied over 14 weeks, which more closely
mimics an in vivo exposure scenario, but retains the advantages associated with an in vitro assessment.
Through proof of concept experimentation that utilized 50 nm Ag-NPs and keratinocyte cells, this study
identified that in the absence of significant cytotoxicity, distinctive cellular responses arose between the
chronically and the acutely dosed cells; including a long term stress response, substantial modifications
to gene regulation, and an increased EGF signaling efficiency (Figure 6). Using silver nitrate as a
control, it was ascertained that these responses were brought on by a combination of the particles
themselves and their ionic dissolution. These results demonstrate the effectiveness of a chronic in vitro
model to elucidate the long term implications of NM exposure that were previously unobtainable;
improving the ability to accurately evaluate the safety of engineered NMs.
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Figure 6. Summary of the differential response to Ag-NPs following execution of a chronic dosimetry
delivery system. HaCaTs that underwent a one-time, 24 h exposure to Ag-NPs displayed minimal
cellular alterations. On the contrary, cells that were exposed to the same amounts of Ag-NPs, but
through a through a chronic exposure means, demonstrated significant cellular consequences, including
sustained stress levels, alterations to EGF response, and modified gene expression.

METHODS:
Silver nanoparticle characterization. Citrate stabilized Ag-NPs with a primary particle size of 50
nm were purchased from nanoComposix in solution form. Verification of primary size and spherical
morphology was carried out through TEM analysis (Hitachi H-7600) at 120,000x magnification. The
effective particle size and surface charge were determined with dynamic light scattering and zeta
potential procedures, respectively, using a Malvern Zetasizer Nano-ZS.56 The degree of particle
dissolution after 8 hours at 37 ºC was evaluated by separation of released ions from the Ag-NPs through
tangential flow filtration (Kros Flo Research System, Spectrum Labs) and silver content analysis on a
Perkin Elmer NexION 300D inductive coupled plasma mass spectrometry (ICP-MS).

ALF was

constructed from a previously published recipe57 and used to evaluate the dissolution rate in intracellular
vacuoles. The deposition efficiency was determined by the incubation of HaCaT cells with 400 pg/mL
Ag-NPs for 8 hours at 37 ºC, the chronic exposure conditions; followed by the removal and
quantification of silver within the supernatant via ICP-MS analysis.
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Implementation of a chronic in vitro model for nanoparticle exposure. The human keratinocyte
cell line HaCaT were a kind gift from the Army Research Laboratory and cultured in RMPI-1640
medium (ATCC) supplemented with 10% heat inactivated fetal bovine serum (ATCC) and 100 U/mL
penicillin and 100 µg/mL streptomycin. To mimic occupational exposure, cells were exposed to the
stated Ag-NP concentrations (2 mL) for 8 hours per day, Monday through Friday. After the 8 hour
exposure, the media was collected and stored at -80 ºC, and cells were washed and replenished with
fresh media. HaCaT cultures were split every Friday evening to a density of 5 X 104 viable cells per
well in a 6-well plate and incubated at 37ºC in a humidified atmosphere containing 5% CO2. During
cell passage, the viability of the HaCaT cultures was determined to verify that a cytotoxic response was
not occurring. Throughout the course of this experiment the viability at HaCaT splitting was found to
be 95% or higher, indicating no loss of viability. This chronic dosing procedure continued for a total
duration of 14 weeks (3 months) and was repeated with three independent sets to allow for the statistical
analysis to be carried out. Silver nitrate exposed cells followed the same procedure for chronic delivery.

Silver nanoparticle retention. For quantitative analysis, HaCaT cells were seeded in a six-well plate at
a density of 8 × 105 cells/well, dosed with their respective chronic Ag-NP concentrations, and incubated
for 24 hours. The cells were then washed, detached with trypsin, counted, and digested with an aqueous
solution of 0.05% Triton X-100, 3% HCl, and 1% HNO3. The amount of intracellular silver was then
quantified through ICP-MS on a Perkin Elmer NexION 300D (Waltham, MA).
For cellular association studies, 2 x 105 cells were plated per chamber on a 2-well chambered slide
and grown for 24 hours, keeping the same chronic treatment plan as previously outlined. The cells were
then fixed with 4% paraformaldehyde and incubated with Alexa Fluor 555-phalloidin for actin staining
and DAPI for nuclear staining (Invitrogen, Carlsbad, CA, USA). The slides were then sealed and
imaged using a CytoViva 150 ultraresolution attachment on an Olympus BX41 microscope (Aetos
Technologies, Inc., Auburn, AL, USA).
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Confocal imaging and evaluation. In a 96-well plate HaCaT cells were seeded at a density of 2 x
105 per mL the day before experimentation. They were then dosed with the denoted Ag-NPs for 24
hours, followed by preparation for confocal imaging.58 Briefly, cells were washed, fixed with 4%
paraformaldehyde (Electron Microscopy Sciences), and permealized with 1% Triton-X100 (Sigma
Aldrich). Fixed HaCaTs were then blocked with 1% bovine serum albumin (Sigma Aldrich), probed
with the targeted primary and secondary antibodies, and imaged on a BD Pathway 435 confocal
microscope using the DAPI, FITC and TRITC filters. Primary antibodies were used to evaluate p38
phosphorylation (Cell Signaling Technology), actin expression (Invitrogen), and ki67 quantities
(Thermo Scientific); with the appropriate corresponding secondary antibodies (Thermo Scientific).
Acquired images underwent analysis using the BD AttoVisionTM and the BD Data Explorer software
packages.

ELISA analysis. For determination of IL-6 and TNF-α the supernatants were removed daily and
stored at -80 ºC until analysis. Concentrations of extracellular IL-6 and TNF-α were quantified using an
ELISA kit (Invitrogen) in accordance with the manufacturer’s protocol. The secreted concentrations of
IL-6 and TNF- α were determined through the use of a set of standards following sequential dilution.
For Akt and Erk analyses, HaCaT cells were seeded in a 6-well plate at a density of 8 x 105 per well
and incubated in serum free media containing the stated Ag-NP concentrations for 24 hours. Cells were
then stimulated with 10 ng/mL EGF for 2 hours, after which they were lysed in a non-denaturing buffer
(Cell Signaling Technology) containing phosphatase and protease inhibitors.

The cell debris was

removed via centrifugation at 15000 rpm for 15 minutes at 4 ᵒC. The supernatants were removed and
stored at -80 ᵒC until analysis. The phosphorylation levels of Akt and Erk were ascertained with ELISA
kits (Cell Signaling Technology) and normalized by the total amount of the same protein, quantified in
parallel.
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Real time PCR arrays. Cells were seeded in a 6-well plate at a density of 8 x 105 per well and
incubated overnight. The following day HaCaT cultures were exposed to the stated Ag-NP conditions
for a duration of 24 hours. For EGF dependent gene regulation, cells were incubated in serum free
media then stimulated with 10 ng/mL EGF for 2 hours. The RNA was then isolated using the RNeasy
Mini Kit (Qiagen), quantified on a NanoDrop spectrophotometer (Thermo Scientific), and processed for
PCR array analysis with the RT2 First Strand kit (Qiagen). The PCR arrays (human stress and toxicity
or human EGF/PDGF signaling - Qiagen) were run in accordance with the manufacturer’s protocol.

Statistical analysis. Data is expressed as the mean ± the standard error of the mean (SEM). A two
way ANOVA with a Bonferroni post-test was run using Graph Pad Prism to determine statistical
significance. Significance was indicated for a p-value less than 0.05. PCR arrays were analyzed with
the aid of the Qiagen software with denoted gene alterations have a fold regulation over 2.0 and p-value
less than 0.05.

ACKNOWLEDGMENT: The authors thank Ms. E. Breitner for assistance with the daily NM
dosing. This work was supported in part from the Air Force Surgeon General and the Air Force Office
of Scientific Research. K.K.C. was funded through a postdoctoral fellowship from the Oak Ridge
Institute for Science and Education and through the Summer Faculty Fellowship Program sponsored
through the Air Force Office of Scientific Reserach. L.B.-S. and E.I.M. received funding from the
Henry M. Jackson Foundation.
SUPPORTING INFORMATION AVAILABLE: Dose dependent Ag-NP toxicity, cytotoxicity
following chronic exposure, stress response at concentrations of 0.4 and 4 pg/mL, EGF signaling
efficiency at concentrations of 0.4 and 4 pg/mL, HaCaT response to acute exposure with a 5 μg/mL
dose, and silver nitrate cytotoxicity. This information is available free of charge via the Internet at
http://pubs.acs.org.

25

REFERENCES
1. Maynard, A. D. Nanotechnology: Assessing the Risks. Nano Today 2006, 1, 22–33.
2. Oberdörster, G.; Oberdörster, E.; Oberdörster, J. Nanotoxicology: An Emerging Discipline
Evolving From Studies of Ultrafine Particles. Environ. Health Perspect. 2005, 113, 823–839.
3. Nel, A.; Xia, T.; Li, N. Toxic Potential of Materials at the Nanolevel. Science 2006, 311, 622–627.
4. Xia, T.; Li, N.; Nel, A. E. Potential Health Impact of Nanoparticles. Annu. Rev. Public Health
2009, 30, 137–150.
5. Hussain, S. M.; Braydich-Stolle, L. K.; Schrand, A. M.; Murdock, R. C.; Yu, K. O.; Mattie, D. M.;
Schlager, J. J.; Terrones, M. Toxicity Evaluation for Safe Use of Nanomaterials: Recent
Achievements and Technical Challenges. Adv. Mater. 2009, 21, 1549–1559.
6. Kang, G. S.; Gillespie, P. A.; Gunnison, A.; Moreira, A. L.; Tchou-Wong, K.; Chen, L. LongTerm Inhalation Exposure to Nickel Nanoparticles Exacerbated Atherosclerosis in a Susceptible
Mouse Model. Environ. Health Perspect. 2011, 119, 176–181.
7. Stebounova, L. V.; Morgan, H.; Grassian, V. H.; Brenner, S. Health and Safety Implications of
Occupational Exposure to Engineered Nanomaterials. WIREs Nanomed. Nanobiotechnol. 2012, 4,
310–321.
8. Arora, S.; Rajwade, J. M.; Paknikar, K. M. Nanotoxicology and in Vitro Studies: The Need of the
Hour. Toxicol. Appl. Pharmacol. 2012, 258, 151–165.
9. Braydich-Stolle, L. K.; Speshock, J. L.; Castle, A. A.; Smith, M. M.; Murdoch, R. C.; Hussain, S.
M. Nanosized Aluminum Altered Immune Function. ACS Nano 2010, 4, 3661–2670.
10. Elsaesser, A.; Howard, C. V. Toxicology of Nanoparticles. Adv. Drug Delivery Rev. 2012, 64,
129–137.

26

11. Sayes, C. M.; Reed; K. L.;Warheit, D. B. Assessing Toxicity of Fine and Nanoparticles:
Comparing in Vitro Measurements to in Vivo Pulmonary Toxicity Profiles. Toxicol. Sci. 2007, 97,
163–180.
12. Warheit, D. B.; Sayes, C. M.; Reed, K. L. Nanoscale and Fine Zinc Oxide Particles: Can in Vitro
Assays Accurately Forecast Lung Hazards Following Inhalation Exposures? Environ. Sci.
Technol. 2009, 43, 7939–7945.
13. Wang, L.; Luanpitpong, S.; Castranova, V.; Tse, W.; Lu, Y.; Pongrakhananon, V.; Rojanasakul,
Y. Carbon Nanotubes Induce Malignant Transformation and Tumorigenesis of Human Lung
Epithelial Cells. Nano Lett. 2011, 11, 2796–2803.
14. Teeguarden, J. G.; Hinderliter, P. M.; Orr, G.; Thrall, B. D.; Pounds, J. G. Particokinetics in Vitro:
Dosimetry Considerations for in Vitro Nanoparticle Toxicity Assessments. Toxicol. Sci. 2007, 95,
300–312.
15. National Institute of Occupational Safety and Health.

Current Intelligence Bulletin 63:

Occupational Exposure to Titanium Dioxide. DHHS (NIOSH) Publication Number 2011–160.
16. van Broekhuizen, P.; van Veelen, W.; Streekstra, W. H.; Schulte, P.; Reijnders, L. Exposure
Limits for Nanoparticles: Report of an International Workshop on Nano Reference Values. Ann.
Occup. Hyg. 2012, 56, 515–524.
17. AshaRani, P. V.; Mun, G. L. K.; Hande, M. P.; Valiyaveettil, S. Cytotoxicity and Genotoxicity of
Silver Nanoparticles in Human Cells. ACS Nano 2009, 3, 279–290.
18. Braydich-Stolle, L. K.; Lucas, B.; Schrand, A.; Murdock, R. C.; Lee, T.; Schlager, J. J.; Hussain,
S. M.; Hofmann, M. C. Silver Nanoparticles Disrupt GDNF/Fyn Kinase Signaling in
Spermatogonial Stem Cells. Toxicol. Sci. 2010, 116, 577–589.

27

19. Carlson, C.; Hussain, S. M.; Schrand, A. M.; Braydich-Stolle, L. K.; Hess, K. L.; Jones, R. L.;
Schlager, J. J. Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation of
Reactive Oxygen Species. J. Phys. Chem. B 2008, 112, 13608–13619.
20. Comfort, K. K.; Maurer, E. I.; Braydich-Stolle, L. K.; Hussain, S. M. Interference of Silver, Gold,
and Iron Oxide Nanoparticles on Epidermal Growth Factor Signal Transduction in Epithelial
Cells. ACS Nano 2011, 5, 10000–100008.
21. Hussain, S. M.; Hess, K. L.; Gearhart, J. M.; Geiss, K. T.; Schlager, J. J. In Vitro Toxicity of
Nanoparticles in BRL 3A Rat Liver Cells. Toxicol. in Vitro 2005, 19, 975–983.
22. Colvin, V. L. The Potential Environmental Impact of Engineered Nanomaterials. Nat. Biotechnol.
2003, 21, 1166–1170.
23. Yang, X.; Liu, J.; He, H.; Zhou, L.; Gong, C.; Wang, X.; Yang, L.; Yuan, J.; Huang, H.; He, L.; et
al. SiO2 Nanoparticles Induce Cytotoxicity and Protein Expression Alteration in HaCaT Cells.
Part. Fibre Toxicol. 2010, 7, 1.
24. Liang, H.; Jin, C.; Tang, Y.; Wang, F.; Ma, C.; Yang, Y. Cytotoxicity of Silica Nanoparticles on
HaCaT Cells. J. Appl. Toxicol. 2014, 34, 367–372.
25. DeBrosse, M. C.; Comfort, K. K.; Untener, E. A.; Comfort, D. A.; Hussain, S. M. High Aspect
Ratio Gold Nanorods Displayed Augmented Cellular Internalization and Surface Chemistry
Mediated Cytotoxicity. Mater. Sci. Eng. C 2013, 33, 4094–4100.
26. Comfort, K. K.; Maurer, E. I.; Hussain, S. M. The Biological Impact of Concurrent Exposure to
Metallic Nanoparticles and a Static Magnetic Field. Bioelectromagnetics. 2013, 34, 500–511.
27. Elder, A.; Vidyasagar, S.; DeLouise, L. Physicochemical Factors that Affect Metal and Metal
Oxide Nanoparticle Passage Across Epithelial Barriers. WIREs Nanomed. Nanobiotechnol. 2009,
1, 434–450.

28

28. Prabhu, S.; Poulose, E. K. Silver Nanoparticles: Mechanism of Antimicrobial Action, Synthesis,
Medical Applications, and Toxicity Effects. Int. Nano Lett. 2012, 2, 32.
29. Drake, P. L.; Hazelwood, K. J. Exposure-related Health Effects of Silver and Silver Compounds:
A Review. Ann. Occup. Hyg. 2005, 49, 575–585.
30. Nel, A .E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.;
Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio
Interface. Nat. Mater. 2009, 8, 543–557.
31. Rivera Gil, P.; Oberdorster, G.; Elder, A.; Puntes, V.; Parak, W. J. Correlating Physico-Chemical
with Toxicological Properties of Nanoparticles: The Present and the Future. ACS Nano 2010, 4,
5527–5531.
32. Lynch, I.; Salvati, A.; Dawson, K. A. Protein-Nanoparticle Interactions: What Does the Cell See?
Nat. Nanotechnol. 2009, 4, 546–547.
33. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle Size and
Surface Properties Determine the Protein Corona with Possible Implications for Biological
Impacts. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 14265–14270.
34. Maurer, E. I.; Sharma, M.; Schlager, J. J.; Hussain, S. M. Systematic Analysis of Silver
Nanoparticle Ionic Dissolution by Tangential Flow Filtration: Toxicological Implications.
Nanotoxicology 2013, 8, 718–727.
35. Kittler, S.; Greulich, C.; Diendorf, J.; Köller, M.; Epple, M. Toxicity of Silver Nanoparticles
Increases During Storage Because of Slow Dissolution Under Release of Silver Ions. Chem.
Mater. 2010, 22, 4548–4554.
36. Beer, C.; Foldbjerg, R.; Hayashi, Y.; Sutherland, D.S.; Autrup, H. Toxicity of Silver Nanoparticles
– Nanoparticle or Silver Ion? Toxicol. Lett. 2012, 208, 286–292.

29

37. Untener, E. A.; Comfort, K. K.; Maurer, E. I.; Grabinski, C. M.; Comfort, D. A.; Hussain, S. M.
Tannic Acid Coated Gold Nanorods Demonstrate a Distinctive Form of Endosomal Uptake and
Unique Distribution within cells. ACS Appl. Mater. Interfaces 2013, 11, 8366–8373.
38. Yue, T.; Zhang, X. Cooperative Effect in Receptor-Mediated Endocytosis of Multiple
Nanoparticles. ACS Nano 2012, 6, 3196–3205.
39. Comfort, K. K.; Speltz, J. W.; Stacy, B. M.; Dosser, L. R.; Hussain, S. M. Physiological Fluid
Specific Agglomeration Patterns Diminish Gold Nanorod Photothermal Characteristics. Adv.
Nanopart. 2013, 2, 336–343.
40. Cho, W. S.; Duffin, R.; Howie, S. E.; Scotton, C. J.; Wallace, W. A.; MacNee, W.; Bradley, M.;
Megson, I. L.; Donaldson, K. Progressive Severe Lung Injury by Zinc Oxide Nanoparticles; The
Role of Zn2+ Dissolution Inside Lysosomes. Part. Fibre Toxicol. 2011, 8, 27.
41. Kim, J. A.; Aberg, C.; Salvati, A.; Dawson, K. A. Role of Cell Cycle on the Cellular Uptake and
Dilution of Nanoparticles in a Cell Population. Nat. Nanotechnol. 2012, 7, 62–68.
42. Halliwell, B. Free Radicals, Proteins and DNA. Oxidative Damage Versus Redox Regulation.
Biochem. Soc. Trans. 1996, 24, 521S.
43. Whitmarsh, A. J. A Central Role for p38 MAPK in the Early Transcriptional Response to Stress.
BMC Biol. 2010, 8, 1–3.
44. Eom, H. J.; Choi, J. p38 MAPK Activation, DNA Damage, Cell Cycle Arrest and Apoptosis as
Mechanisms of Toxicity of Silver Nanoparticles in Jurkat T Cells. Environ. Sci. Technol. 2010, 44,
8337–8342.
45. Ahamad, M.; Posgai, R.; Gorey, T. J.; Nielsen, M.; Hussain, S. M.; Rowe, J. J. Silver
Nanoparticles Induced Heat Shock Protein 70, Oxidative Stress, and Apoptosis in Drosophila
Melanogaster. Tox. Appl. Pharm. 2010, 242, 263–269.

30

46. Huot, J.; Houle, F.; Marceau, F.; Landry, J. Oxidative Stress–Induced Actin Reorganization
Mediated by the p38 Mitogen-Activated Protein Kinase/Heat Shock Protein 27 Pathway in
Vascular Endothelial Cells. Circ. Res. 1997, 80, 383–392.
47. Bullwinkel, J.; Baron-Lühr, B.; Lüdemann, A.; Wohlenberg, C.; Gerdes, J.; Scholzen, T. Ki-67
Protein is Associated with Ribosomal RNA Transcription in Quiescent and Proliferating Cells. J.
Cell. Physiol. 2006, 206, 624–635.
48. Suliman, Y. A.; Ali, D.; Alarifi, S.; Harrath, A. H.; Mansour, L.; Alwasel, S. H. Evaluation of
Cytotoxic, Oxidative Stress, Proinflammatory and Genotoxic Effect of Silver Nanoparticles in
Human Lung Epithelial Cells. Environ. Toxicol. 2013, doi: 10.1002/tox.21880.
49. Rangel-Frausto, M. S.; Pittet, D.; Costigan, M.; Hwang, T.; Davis, C. S.; Wenzel, R. P. The
Natural History of the Systemic Inflammatory Response Syndrome (SIRS). J. Am. Med. Assoc.
1995, 273, 117–123.
50. Pastore, S.; Mascia, F.; Mariani, V.; Girolomoni, G. The Epidermal Growth Factor Receptor
System in Skin Repair and Inflammation. J. Invest. Dermotol. 2008, 128, 1365–1374.
51. Egeblad, M.; Werb, Z. New Functions for the Matrix Metalloproteinsases in Cancer Progression.
Nat. Rev. Cancer 2002, 2, 161–174.
52. Zhang, Y.; Wolf-Yadlin, A.; Ross, P. L.; Pappin, D. J.; Rush, J.; Lauffenburger, D. A.; White, F.
M. Time-Resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal
Growth Factor Receptor Signaling Network Reveals Dynamic Modules. Mol. Cell. Proteomics
2005, 4, 1240–1250.
53. Kulthong, K.; Srisung, S.; Boonpavanitchakul, K.; Kangwansupamonkon, W.; Maniratanachote,
R. Determination of Silver Nanoparticle Release from Antibacterial Fabrics Into Artificial Sweat.
Part. Fibre Toxicol. 2010, 7, 8.

31

54. Qian, X.; Peng, X. H.; Ansari, D. O.; Yin-Goen, Q.; Chen, G. Z.; Shin, D. M.; Yang, L.; Young,
A. N.; Wang, M. D.; Nie, S. In Vivo Tumor Targeting and Spectroscopic Detection with SurfaceEnhanced Raman Nanoparticle Tags. Nat. Biotechnol. 2008, 26, 83–90.
55. Geiser, M.; Kreyling, W. G. Deposition and Biokinetics of Inhaled Nanoparticles. Part. Fibre
Toxicol. 2010, 7, 2.
56. Murdock, R. C.; Braydich-Stolle, L.; Schrand, A. M.; Schlager, J. J.; Hussain, S. M.
Characterization of Nanomaterial Dispersion in Solution Prior to in Vitro Exposure Using
Dynamic Light Scattering. Toxicol. Sci. 2008, 101, 239–253.
57. Stopford, W.; Turner, J.; Cappellini, D.; Brock, T. Bioaccessibility Testing of Cobalt Compounds.
J. Environ. Monit. 2003, 5, 675–680.
58. Braydich-Stolle, L. K.; Castle, A. B.; Maurer, E. I.; Hussain, S. M. Advantages of Using ImagedBased Fluorescent Analysis for Nanomaterial Studies. Nanosci. Meth. 2012, 1, 137–151.

Graphical TOC Entry:
Chronic, Low
Dosages

EGF
ki67

Ag-NPs

Basal
Stress
ki67

Akt &
Erk

Gene
Modification

Modified
Cell
Functionality

32

